Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01050 |
| Species: | Homo sapiens |
| Position : | chr1:85865000-85866500 |
| Year: | 2019 |
| Title: | KDM3A regulates hippo pathway through enhancer activation in colorectal cancer |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | colorectal carcinoma |
| PMID: | 30649550 |
| MONDO: | MONDO:0005132 |
| Tissue: | Colon |
| Tissue Ontology ID: | UBERON:0001155 |
| Cell Source: | HCT116 |
| CVCL ID: | CVCL_0291 |
| Cell Type: | colorectal carcinoma cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Functional perturbation assay, TF binding assay, Enhancer activity assay |
| High Throughput Method: | ChIP-seq, RNA-seq |
| Low Throughput Method: | CRISPR knockout, ChIP-RT-qPCR, RT-RT-qPCR, Western blot, Co-IP |
| Target gene : | CYR61 |
| TF name : | TEAD1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| TEAD1 | PPARA activates gene expression | reactome | 113 |
| TEAD1 | YAP1- and WWTR1 (TAZ)-stimulated gene expression | reactome | 29 |
| TEAD1 | Hs_Mesodermal_Commitment_Pathway_WP2857_87780 | wikipathways | 47 |